Usana Health Sciences fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
10/09/2025 | USNA | Usana Health Sciences | Q3 | 2025 | -$0.15 | -$0.15 | $0.47 | $214.00M | $214.00M | $224.13M | |
07/22/2025 | USNA | Usana Health Sciences | FY | 2025 | $2.35 | $3.00 | $2.61 | $920.00M | $1.00B | $946.98M | |
04/22/2025 | USNA | Usana Health Sciences | FY | 2025 | $2.35 | $3.00 | $2.59 | $920.00M | $1.00B | $941.62M | |
02/25/2025 | USNA | Usana Health Sciences | FY | 2025 | $2.35 | $3.00 | $2.87 | $920.00M | $1.00B | $934.51M | |
10/22/2024 | USNA | Usana Health Sciences | FY | 2024 | $2.45 | $2.45 | $2.50 | $850.00M | $850.00M | $861.94M | |
07/23/2024 | USNA | Usana Health Sciences | FY | 2024 | $2.40 | $2.55 | $2.78 | $850.00M | $880.00M | $883.52M | |
04/30/2024 | USNA | Usana Health Sciences | FY | 2024 | $2.40 | $3.00 | $2.72 | $850.00M | $920.00M | $889.79M | |
02/06/2024 | USNA | Usana Health Sciences | FY | 2024 | $2.40 | $3.00 | $2.94 | $850.00M | $920.00M | $912.33M | |
10/24/2023 | USNA | Usana Health Sciences | FY | 2023 | $2.80 | $3.05 | $3.13 | $900.00M | $920.00M | $930.06M | |
07/25/2023 | USNA | Usana Health Sciences | FY | 2023 | $2.65 | $3.30 | $3.02 | $900.00M | $950.00M | $940.57M | |
04/25/2023 | USNA | Usana Health Sciences | FY | 2023 | $2.40 | $3.30 | $2.85 | $875.00M | $950.00M | $935.33M | |
02/07/2023 | USNA | Usana Health Sciences | FY | 2023 | $2.35 | $3.30 | $3.35 | $850.00M | $950.00M | $959.85M | |
01/05/2023 | USNA | Usana Health Sciences | FY | 2023 | $2.35 | $3.30 | $3.35 | $850.00M | $950.00M | $959.85M | |
01/05/2023 | USNA | Usana Health Sciences | FY | 2022 | $3.65 | $3.65 | $3.28 | $995.00M | $995.00M | $974.43M | |
10/25/2022 | USNA | Usana Health Sciences | FY | 2022 | $3.15 | $3.40 | $3.90 | $955.00M | $975.00M | $1.03B | |
07/26/2022 | USNA | Usana Health Sciences | FY | 2022 | $3.85 | $4.45 | $4.42 | $1.01B | $1.06B | $1.06B | |
07/06/2022 | USNA | Usana Health Sciences | Q2 | 2022 | $1.05 | $1.05 | $1.26 | $265.00M | $265.00M | $272.77M | |
07/06/2022 | USNA | Usana Health Sciences | FY | 2022 | $3.85 | $4.45 | $5.27 | $1.01B | $1.06B | $1.13B | |
04/26/2022 | USNA | Usana Health Sciences | FY | 2022 | $5.00 | $5.70 | $5.46 | $1.10B | $1.20B | $1.14B | |
02/08/2022 | USNA | Usana Health Sciences | FY | 2022 | $5.25 | $6.00 | $5.78 | $1.13B | $1.23B | $1.17B | |
10/26/2021 | USNA | Usana Health Sciences | FY | 2021 | $5.80 | $6.00 | $5.93 | $1.18B | $1.20B | $1.19B | |
09/16/2021 | USNA | Usana Health Sciences | Q3 | 2021 | $1.28 | $1.33 | $1.44 | $265.00M | $270.00M | $303.24M | |
09/16/2021 | USNA | Usana Health Sciences | FY | 2021 | $5.80 | $6.00 | $6.35 | $1.18B | $1.20B | $1.26B | |
07/27/2021 | USNA | Usana Health Sciences | FY | 2021 | $6.15 | $6.50 | $6.37 | $1.24B | $1.28B | $1.27B | |
04/27/2021 | USNA | Usana Health Sciences | FY | 2021 | $6.15 | $6.50 | $6.28 | $1.24B | $1.28B | $1.24B | |
02/09/2021 | USNA | Usana Health Sciences | FY | 2021 | $6.00 | $6.45 | $5.77 | $1.21B | $1.27B | $1.19B |
Le ultime previsioni per Usana Health Sciences (USNA) sono state riportate il ottobre 9, 2025 per Q3 2025. L'azienda ha fornito una previsione di utili per azione nell'intervallo da $-0.15 a $-0.15, rispetto all'EPS stimato di $0.47. Inoltre, Usana Health Sciences ha previsto ricavi tra $0.21B e $0.21B per il trimestre.
Sfoglia guidance e previsioni su tutte le azioni.